Clinical Trials
3 trialsNCT05688306 2023-01-18
To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment
Liaoning Cancer Hospital & Institute
Completed
NCT01663441 2020-09-16
A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11
Beijing Northland Biotech. Co., Ltd.
Phase 3 Completed
NCT00493181 2012-02-20
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
M.D. Anderson Cancer Center
Phase 2 Completed